Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4.99M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
17M
-
Shares change
-
+17M
-
Total reported value, excl. options
-
$236M
-
Value change
-
+$236M
-
Number of buys
-
29
-
Price
-
$13.97
Significant Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q2 2017
29 filings reported holding MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2017.
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17M shares
.
Largest 10 shareholders include NEA Management Company, LLC (8.14M shares), WELLINGTON MANAGEMENT GROUP LLP (2.05M shares), FMR LLC (1.74M shares), Rock Springs Capital Management LP (1.53M shares), ProQuest Associates IV LLC (956K shares), RHO CAPITAL PARTNERS INC (818K shares), ArrowMark Colorado Holdings LLC (350K shares), JPMORGAN CHASE & CO (341K shares), SCOPIA CAPITAL MANAGEMENT LP (204K shares), and Alyeska Investment Group, L.P. (125K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.